Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy

NCT02145390 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT02145390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02145390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Lead sponsor
University of Miami
Phase
Not applicable
Overall status
Terminated
Start date
January 5, 2016
Completion date
April 25, 2017
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder carcinoma, muscle invasive bladder carcinoma, transition cell cancer